Attention Control Training for Infants at Risk of ADHD (INTERSTAARS)

  • Research type

    Research Study

  • Full title

    Attention Control Training for Infants at risk of ADHD: a randomized controlled trial

  • IRAS ID

    170342

  • Contact name

    Mark Johnson

  • Contact email

    mark.johnson@bbk.ac.uk

  • Sponsor organisation

    Birbeck, University of London

  • Research summary

    Attention deficit/hyperactivity disorder (ADHD) is a developmental condition that significantly impacts on education,
    social and life outcomes. Medication is often used as a treatment but has significant limitations. Psychological
    approaches, although more acceptable to many, have proved disappointing in their effectiveness, because they are
    administered too late in development. The most effective time to intervene is likely in infancy, before the disorder fully
    develops and when brains are more amenable to positive environmental effects. To test this idea we will undertake a
    trial of a novel computerbased
    attention training treatment for infants at increased genetic risk for ADHD. The training
    approach uses state of the art technology to link attention allocation (as measured by infant gaze) to rewarding images
    and outcomes on the screen – thus reinforcing concentration and strengthening attention capacity (as previously
    shown in typically developing infants). We are interested here in whether such effects can also be seen in infants at
    risk for ADHD, whether there are any beneficial effects on early manifestations of ADHDlike
    behaviours, and what the
    brain processes underpinning such effects might be. Up to 80 infants will take part in this initial study. Participants will
    be at increased genetic risk of ADHD as they have an immediate family member with the condition. Half of them will get
    12 homebased
    sessions of the attention training treatment. The others will receive a control placebo training. If the
    initial trial is successful, we will plan a larger scale effectiveness randomized controlled trial (RCT) in the near future.
    To note, this study will be affiliated with the STAARS study, therefore some STAARS participants will be also invited to
    participate in INTERSTAARS,
    and INTERSTAARS
    volunteers will be invited to participate in STAARS.

  • REC name

    London - Central Research Ethics Committee

  • REC reference

    15/LO/0407

  • Date of REC Opinion

    27 Mar 2015

  • REC opinion

    Favourable Opinion